CTNNB1 mutationBiomarker1 paperHuman trial1LatestJournal of Clinical Oncology·26 JanPhase II study of everolimus and letrozole in patients with recurrent endometrial carcinomaNon-randomised trial in 38 peoplemTOR inhibitorsPaper
Journal of Clinical Oncology·26 JanPhase II study of everolimus and letrozole in patients with recurrent endometrial carcinomaNon-randomised trial in 38 peoplemTOR inhibitorsPaper